The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countries
Abstract
In developed countries, the incidence of hepatitis E virus (HEV) infection and the resulting seroprevalence are uncertain. Published estimates of seroprevalnce in these populations range from 0.26% to 31%, which may in part reflect the variety of assays used by different studies. This study compared the performance of two commercial assays (Genelabs [Singapore] and Wantai ‘Beijing, China’ HEV IgG EIA kits) and reviewed published estimates of anti‐HEV seroprevalence in developed countries. The assays were compared using the WHO anti‐HEV reference serum, sera from UK‐acquired cases of genotype 3 HEV infections and 500 UK blood donor sera. The PE2 assay was found to be more sensitive than the GL assay (lower limit of detection for HEV IgG 0.25 vs. 2.5 WHO units/ml); it was positive in more sera from proven cases (98% vs. 56%), remained positive for longer post infection and resulted in a substantially higher estimate of seroprevalence in blood donors (16.2% vs. 3.6%). these results suggest that published studies of HEV seroprevalence using the GL assay have underestimated the true figure and that a properly validated method is required to make meaningful comparisons of HEV seroprevalence between populations. J. Med. Virol. 82: 799–805, 2010. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatitis E: an emerging infection in developed countries
Dalton, H. R., Bendall, R., Ijaz, S., & Banks, M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70255-x · Cited by 669
Self-citationMeng, X. J., Wiseman, B., Elvinger, F., Guenette, D. K., Toth, T. E., Engle, R. E., Emerson, S. U., & Purcell, R. H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.1.117-122.2002 · Cited by 520
Dalton, H. R., Stableforth, W., Thurairajah, P., Hazeldine, S., Remnarace, R., Usama, W., Farrington, L., Hamad, N., Sieberhagen, C., Ellis, V., et al. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f5195a · Cited by 290
Self-citationLi, S. W., Zhang, J., Li, Y. M., Ou, S. H., Huang, G. Y., He, Z. Q., Ge, S. X., Xian, Y. L., Pang, S. Q., Ng, M. H., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.064 · Cited by 239
Seroreactivity to hepatitis E virus in areas where the disease is not endemic
Thomas, D. L., Yarbough, P. O., Vlahov, D., Tsarev, S. A., Nelson, K. E., Saah, A. J., & Purcell, R. H. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.5.1244-1247.1997 · Cited by 230
Hepatitis E Virus Antibody Prevalence among Persons Who Work with Swine
Drobeniuc, J., Favorov, M. O., Shapiro, C. N., Bell, B. P., Mast, E. E., Dadu, A., Culver, D., Iarovoi, P., Robertson, B. H., & Margolis, H. S. (2001) · The Journal of Infectious Diseases · doi:10.1086/324566 · Cited by 223
Christensen, P. B., Engle, R. E., Hjort, C., Homburg, K. M., Vach, W., Georgsen, J., & Purcell, R. H. (2008) · Clinical Infectious Diseases · doi:10.1086/591970 · Cited by 186
High prevalence of anti‐hepatitis E virus antibodies in blood donors from South West France
Mansuy, J. M., Legrand‐Abravanel, F., Calot, J. P., Peron, J. M., Alric, L., Agudo, S., Rech, H., Destruel, F., & Izopet, J. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21056 · Cited by 177
Hepatitis E in the Netherlands: imported and endemic
Zaaijer, H. L., Kok, M., Lelie, P. N., Timmerman, R. J., Chau, K. H., & van der Pal, H. J. H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90599-c · Cited by 133
Bouwknegt, M., ENGEL, B., Herremans, M. M. P. T., Widdowson, M., Worm, H. C., Koopmans, M., Frankena, K., Husman, A. D. R., de Jong, M. C. M., & van der Poel, W. H. M. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807008941 · Cited by 129
Cited by
Kamar, N., Dalton, H. R., Abravanel, F., & Izopet, J. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-13 · Cited by 675
Self-citationEASL Clinical Practice Guidelines on hepatitis E virus infection
Dalton, H. R., Kamar, N., Baylis, S. A., Moradpour, D., Wedemeyer, H., & Negro, F. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.005 · Cited by 665
Self-citationHoofnagle, J. H., Nelson, K. E., & Purcell, R. H. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204512 · Cited by 479
Hepatitis-E-Virus: Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
Gesundheit, M. D. A. B. D. B. F. (2015) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2103-4 · Cited by 374
Risk factors and sources of foodborne hepatitis E virus infection in the United States
Cossaboom, C. M., Heffron, C. L., Cao, D., Yugo, D. M., Houk‐Miles, A. E., Lindsay, D. S., Zajac, A. M., Bertke, A. S., Elvinger, F., & Meng, X. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24497 · Cited by 53
Metadata
- Authors
- Bendall, R., Ellis, V., Ijaz, S., Ali, R., & Dalton, H.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2010-03-24
- Volume
- 82
- Issue
- 5
- Pages
- 799-805
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W1989751941
- Cited by
- 309
- References
- 20
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countries. https://app.cochat.ai/papers/10.1002/jmv.21656
- The paper
- Bendall, R., Ellis, V., Ijaz, S., Ali, R., & Dalton, H. (2010). A comparison of two commercially available anti‐HEV IgG kits and a re‐evaluation of anti‐HEV IgG seroprevalence data in developed countries. Journal of Medical Virology. https://doi.org/10.1002/jmv.21656
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.